Quarterly report pursuant to Section 13 or 15(d)

Share-based Payments

v3.5.0.2
Share-based Payments
9 Months Ended
Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based Payments

Note 9 - Share-based Payments

 

On January 23, 2014, upon effectiveness of the registration statement filed with the SEC, the Company adopted the 2013 Stock Incentive Plan (the “Plan”) which will provide for the issuance of up to 400,000 shares. The purpose of the Plan is to provide additional incentive to those officers, employees, consultants and non-employee directors of the Company and its parents, subsidiaries and affiliates whose contributions are essential to the growth and success of the Company’s business. 

 

On January 9, 2015, the Board of Directors of the Company approved, upon recommendation from the Compensation Committee of the Board, by unanimous written consent the Amended and Restated 2013 Incentive Stock and Award Plan (the “Plan”), which increases the number of authorized shares of common stock subject to the Plan to 800,000 shares.

 

On September 30, 2016, the Board of Directors increased the number of authorized shares of common stock subject to the Amended and Restated 2013 Incentive Stock and Award Plan to 830,000 shares. As of September 30, 2016, under the 2013 Plan, grants of restricted stock and options to purchase 277,333 shares of common stock have been issued and are unvested or unexercised and 73,292 shares of common stock remain available for grants.

 

The 2013 Plan may be administered by the board or a board-appointed committee. Eligible recipients of option awards are employees, officers, consultants or directors (including non-employee directors) of the Company or of any parent, subsidiary or affiliate of the Company. The board has the authority to grant to any eligible recipient any options, restricted stock or other awards valued in whole or in part by reference to, or otherwise based on the Company’s common stock.

 

On January 1, 2016, the Company approved the issuance of 12,500 options to purchase common shares to a key consultant for services at an exercise price of $3.70 per common share with vesting over one year.

 

On August 9, 2016 the Company approved the issuance of 26,000 options to purchase common shares to two key employees at an exercise price of $3.25 per common share with vesting over two years.

 

These options were issued under the Amended and Restated 2013 Incentive Stock and Award Plan. The options have a five-year expiration.

 

The calculated fair value of the options was distributed to the following categories on the condensed consolidated statement of operations and comprehensive income:

 

    Three months ended     Nine months ended  
    September 30,     September 30,  
Expense Category   2016     2015     2016     2015  
Cost of Goods   $-     $-     $-     $-  
General & Administrative     -       -       -       -  
Sales & Marketing     22,828       -       31,069       -  
Research & Development     15,435       -       15,435       -  
    $ 38,263     $ -     $ 46,504     $ -  

 

The options and warrants issued under the above plan were valued using a Black Scholes option pricing model. The assumptions utilized in calculating the value of the issued options under Black Scholes are as follows:

 

    2016     2015  
Expected option term     5 yrs        n/a  
Expected volatility     93.08 %      n/a  
Expected divident yeild     0.00 %      n/a  
Risk free interest rate     1.25 %      n/a  

  

Qualified option holders may exercise their options at their discretion. Each option granted may be exchanged for a prescribed number of shares of common stock. The following table summarizes the option activities for the nine months ended September 30, 2016:

 

                  Weighted        
                  Average        
            Weighted     Remaining     Aggregate  
      Number of     Average     Contractual     Intrinsic  
      Shares     Exercise Price     Term (years)     Value  
Balance at December 31, 2015       220,500     $ 4.38                  
Granted       38,500       3.40                  
Exercised       -       -                  
Forfeited       -       -                  
Canceled/Expired       -       -                  
Balance at September 30, 2016       259,000     $ 4.23                  
Exercisable as of September 30, 2016       239,167     $ 4.31       3.30     $ 64,853  

 

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $3.36 for the Company’s common shares on September 30, 2016. The above intrinsic value represents that of awards with an exercise price below $3.36.

 

The total grant date fair value of stock options vested for the three and nine months ended September 30, 2016 was $35,422 and for the three and nine months ended September 30, 2015 was $-.

 

As of September 30, 2016 and December 31, 2015 the Company had 259,000 and 220,500 respectively reserved shares of its common stock for outstanding options.

 

As of September 30, 2016, there was $38,444 of unrecognized compensation cost related to outstanding employee stock options.